HONG KONG — The results of a study by Japanese researchers from the University of Tokyo have helped to elucidate the previously unknown underlying mechanism whereby two commonly prescribed drugs in patients at risk for heart disease can adversely interact, a finding that could lead to improved clinical care of patients taking those medications.
HONG KONG – A highly potent small-molecule inhibitor designed by Korean scientists has been shown both in vivo and in vitro to be a promising candidate treatment for breast cancer that preferentially targets both breast cancer stem cells (BCSCs) and bulk tumor cells, thereby potentially reducing the chances of relapse.
HONG KONG – A highly potent small-molecule inhibitor designed by Korean scientists has been shown both in vivo and in vitro to be a promising candidate treatment for breast cancer that preferentially targets both breast cancer stem cells (BCSCs) and bulk tumor cells, thereby potentially reducing the chances of relapse.
HONG KONG — Japanese researchers have for the first time successfully induced human embryonic stem cells to self-organize into a functional three-dimensional structure similar to the cerebellum, providing clues on how to recreate neural structures in the laboratory and potentially leading to new drug discoveries.
HONG KONG – Japanese researchers have for the first time successfully induced human embryonic stem cells to self-organize into a functional three-dimensional structure similar to the cerebellum, providing clues on how to recreate neural structures in the laboratory and potentially leading to new drug discoveries.
HONG KONG — Researchers from the Riken Institute in Japan have demonstrated for the first time the profound effect that chronic hepatitis infections can have on the genetic mutations found in liver tumors, potentially paving the way for development of tailored therapies for the different types of liver cancer.
HONG KONG — Researchers from the Riken Institute in Japan have demonstrated for the first time the profound effect that chronic hepatitis infections can have on the genetic mutations found in liver tumors, potentially paving the way for development of tailored therapies for the different types of liver cancer.
HONG KONG – The identification of a promising novel candidate therapeutic target in non-small-cell lung cancer (NSCLC) tissue by Chinese researchers could lead to the development of urgently needed new lung cancer immunotherapies.
HONG KONG – The identification of a promising novel candidate therapeutic target in non-small-cell lung cancer (NSCLC) tissue by Chinese researchers could lead to the development of urgently needed new lung cancer immunotherapies.
HONG KONG — The characteristic symptoms of Alzheimer's disease (AD) can be reduced in mice when sugars are prevented from binding to one of the key enzymes implicated in the disease, clearing the way to a new treatment approach, according to researchers from the Riken-Max Planck Joint Research Center in Japan.
